BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 22343031)

  • 1. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
    Holopainen T; Saharinen P; D'Amico G; Lampinen A; Eklund L; Sormunen R; Anisimov A; Zarkada G; Lohela M; Heloterä H; Tammela T; Benjamin LE; Ylä-Herttuala S; Leow CC; Koh GY; Alitalo K
    J Natl Cancer Inst; 2012 Mar; 104(6):461-75. PubMed ID: 22343031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy.
    Albini A; Noonan DM
    J Natl Cancer Inst; 2012 Mar; 104(6):429-31. PubMed ID: 22343030
    [No Abstract]   [Full Text] [Related]  

  • 3. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
    Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
    Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions.
    Zheng W; Nurmi H; Appak S; Sabine A; Bovay E; Korhonen EA; Orsenigo F; Lohela M; D'Amico G; Holopainen T; Leow CC; Dejana E; Petrova TV; Augustin HG; Alitalo K
    Genes Dev; 2014 Jul; 28(14):1592-603. PubMed ID: 25030698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
    Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
    Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
    Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
    Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis.
    De Palma M; Naldini L
    Clin Cancer Res; 2011 Aug; 17(16):5226-32. PubMed ID: 21576085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
    Huang H; Lai JY; Do J; Liu D; Li L; Del Rosario J; Doppalapudi VR; Pirie-Shepherd S; Levin N; Bradshaw C; Woodnutt G; Lappe R; Bhat A
    Clin Cancer Res; 2011 Mar; 17(5):1001-11. PubMed ID: 21233403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.
    Mirando AC; Shen J; Silva RLE; Chu Z; Sass NC; Lorenc VE; Green JJ; Campochiaro PA; Popel AS; Pandey NB
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial destabilization by angiopoietin-2 via integrin β1 activation.
    Hakanpaa L; Sipila T; Leppanen VM; Gautam P; Nurmi H; Jacquemet G; Eklund L; Ivaska J; Alitalo K; Saharinen P
    Nat Commun; 2015 Jan; 6():5962. PubMed ID: 25635707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking Angiopoietin-2 Promotes Vascular Damage and Growth Inhibition in Mouse Tumors Treated with Small Doses of Radiation.
    Kallio P; Jokinen E; Högström J; Das S; Heino S; Lähde M; Brodkin J; Korhonen EA; Alitalo K
    Cancer Res; 2020 Jun; 80(12):2639-2650. PubMed ID: 32312835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
    Song SH; Kim KL; Lee KA; Suh W
    Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.
    Akwii RG; Sajib MS; Zahra FT; Mikelis CM
    Cells; 2019 May; 8(5):. PubMed ID: 31108880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis.
    Gengenbacher N; Singhal M; Mogler C; Hai L; Milde L; Pari AAA; Besemfelder E; Fricke C; Baumann D; Gehrs S; Utikal J; Felcht M; Hu J; Schlesner M; Offringa R; Chintharlapalli SR; Augustin HG
    Cancer Discov; 2021 Feb; 11(2):424-445. PubMed ID: 33106316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.
    Kim M; Allen B; Korhonen EA; Nitschké M; Yang HW; Baluk P; Saharinen P; Alitalo K; Daly C; Thurston G; McDonald DM
    J Clin Invest; 2016 Sep; 126(9):3511-25. PubMed ID: 27548529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
    Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
    Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.